The issue of counterfeiting of drugs has grown as a result of escalating globalisation in both developed and developing nations. As of 2017, "ASSOCHAM" estimates that the bogus medication industry is worth $10 billion annually. WHO estimates that each year, about a million people pass away as a result of fake medications. The pharmaceutical industry's flawed supply chain system is one of the factors contributing to drug counterfeiting. In the current supply chain scenario, either no information is transmitted from one entity to another entity throughout the handoff process, or just minimal or extraneous data about the pharmaceutical formulation is shared within the network. After transferring drugs to another party, the original party is unaware of what will happen to the drugs there. The socioeconomic standing of society is seriously threatened by the counterfeit drug, which also negatively affects patient health and causes legitimate manufacturers to lose money. In this paper we explain how to provide traceability of the pharmaceuticals from their manufacture until their distribution to patients using blockchain technology in the pharmaceutical supply chain, transparency to the drug regulatory body and all the establishment involved in the logistic network. Only trusted parties will be permitted to be the part of network and forward data to the permissioned participants, which will be used to store transactions.